Figure 3.
Swelling and degradation studies of various in situ crosslinking network formulations with (A) or without (B) co-encapsulated microparticles. In vitro release of chemokines from hydrogels. (C) Cumulative release of MIP3α protein from DextranVS-PEG4SH hydrogels and PEGDA-PEG4SH hydrogels (n=6). (D) Cumulative release of MIP3α protein from microparticle-encapsulated DextranVS-PEG4SH hydrogels and PEGDA-PEG4SH hydrogels (n=6).